Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A protease inhibitor being studied as a treatment for hepatitis C.

Etymologies

Sorry, no etymologies found.

Examples

  • Clinical-trial results released so far indicate that both telaprevir and boceprevir appear to work much better than the current treatment, though doctors might prefer telaprevir because it seems easier to use, said Jorge Herrera, a University of South Alabama hepatologist who was an investigator in boceprevir trials and has been traveling around the country lecturing doctors about using the new treatments.

    Strides Against Hepatitis C Open Door to Blockbusters

  • a third antiviral medication called boceprevir, new research suggests.

    Yahoo! News: Business - Opinion

  • The future looks very bright beyond telaprevir and boceprevir, notes Dr. Fred Poordad of Cedars-Sinai Medical Center in Los Angeles, who has studied both drugs and consults for several companies.

    New hope for hepatitis C, an often hidden disease

  • Now major studies show that adding a new drug —either Vertex Pharmaceuticals' telaprevir or Merck & Co.'s boceprevir — can boost those cure rates as high as 75%.

    New hope for hepatitis C, an often hidden disease

  • According to studies presented at a recent medical meeting, 67% to 75% of patients given treatment including either boceprevir or telaprevir, respectively, had what doctors call a cure.

    New hope for hepatitis C, an often hidden disease

  • But as many as 68% of those also receiving boceprevir achieved sustained response at 28 weeks, the researchers found.

    New drug may boost hepatitis C treatment

  • For black patients, the response rate was 23% for those receiving standard care and up to 53% with the addition of boceprevir.

    New drug may boost hepatitis C treatment

  • In the other study, a group led by Dr. Bruce R. Bacon, director of the gastroenterology and hepatology division at St. Louis University Health Sciences Center, tested boceprevir on 403 patients with chronic hepatitis C.

    New drug may boost hepatitis C treatment

  • For those receiving boceprevir, the response rate was as high as 66%, compared with 21% for those receiving only peginterferon and ribavirin, the researchers found.

    New drug may boost hepatitis C treatment

  • The addition of boceprevir to peginterferon-ribavirin resulted in significantly higher rates of sustained virologic response in previously treated patients with chronic HCV hepatitis C genotype 1 infection, as compared with peginterferon-ribavirin alone, the authors concluded.

    New drug may boost hepatitis C treatment

Wordnik is becoming a not-for-profit! Read our announcement here.

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.